AssuredPartners Investment Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.37M Buy
25,321
+869
+4% +$187K 0.62% 40
2026
Q1
$5.05M Buy
24,452
+16,772
+218% +$3.72M 0.55% 45
2025
Q4
$1.75M Buy
7,680
+230
+3% +$52.4K 0.26% 96
2025
Q3
$1.73M Buy
7,450
+226
+3% +$46K 0.38% 50
2025
Q2
$1.34M Sell
7,224
-452
-6% -$84K 0.33% 58
2025
Q1
$1.61M Buy
7,676
+914
+14% +$178K 0.31% 92
2024
Q4
$1.2M Buy
+6,762
New +$1.24M 0.23% 104

Other funds holding ABBV

AssuredPartners Investment Advisors's ABBV Position: Q2 2026 in Review

AssuredPartners Investment Advisors increased its AbbVie (ABBV) stake by 3.6% in Q2 2026, buying an estimated $187K and bringing the position to 25,321 shares worth $6.37M. The position accounts for 0.62% of the portfolio, ranked #40.

AssuredPartners Investment Advisors first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • AssuredPartners Investment Advisors held 25,321 shares of AbbVie worth $6.37M as of Q2 2026.
  • AssuredPartners Investment Advisors bought 869 AbbVie shares in Q2 2026, an estimated $187K.
  • AbbVie made up 0.62% of AssuredPartners Investment Advisors's portfolio in Q2 2026, its #40 holding.
  • AssuredPartners Investment Advisors first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on AssuredPartners Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.